Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 210

1.

Pulmonary surfactant in allergic inflammation: new insights into the molecular mechanisms of surfactant function.

Cochrane CG.

Am J Physiol Lung Cell Mol Physiol. 2005 Apr;288(4):L608-9. No abstract available.

2.

A multicenter, randomized, controlled trial comparing Surfaxin (Lucinactant) lavage with standard care for treatment of meconium aspiration syndrome.

Wiswell TE, Knight GR, Finer NN, Donn SM, Desai H, Walsh WF, Sekar KC, Bernstein G, Keszler M, Visser VE, Merritt TA, Mannino FL, Mastrioianni L, Marcy B, Revak SD, Tsai H, Cochrane CG.

Pediatrics. 2002 Jun;109(6):1081-7.

PMID:
12042546
4.

Bronchopulmonary segmental lavage with Surfaxin (KL(4)-surfactant) for acute respiratory distress syndrome.

Wiswell TE, Smith RM, Katz LB, Mastroianni L, Wong DY, Willms D, Heard S, Wilson M, Hite RD, Anzueto A, Revak SD, Cochrane CG.

Am J Respir Crit Care Med. 1999 Oct;160(4):1188-95.

PMID:
10508806
5.

Surfactant lavage treatment in a model of respiratory distress syndrome.

Cochrane CG, Revak SD.

Chest. 1999 Jul;116(1 Suppl):85S-86S. No abstract available.

PMID:
10424605
6.

Bronchoalveolar lavage with KL4-surfactant in models of meconium aspiration syndrome.

Cochrane CG, Revak SD, Merritt TA, Schraufstätter IU, Hoch RC, Henderson C, Andersson S, Takamori H, Oades ZG.

Pediatr Res. 1998 Nov;44(5):705-15.

PMID:
9803452
7.

Surfactant protein B and mimic peptides in the function of pulmonary surfactant.

Cochrane CG.

FEBS Lett. 1998 Jul 3;430(3):424; discussion 425. No abstract available.

8.

Identification of an N-formyl peptide receptor ligand binding domain by a gain-of-function approach.

Quehenberger O, Pan ZK, Prossnitz ER, Cavanagh SL, Cochrane CG, Ye RD.

Biochem Biophys Res Commun. 1997 Sep 18;238(2):377-81.

PMID:
9299516
9.

In vivo, in vitro, and molecular aspects of interleukin-8 and the interleukin-8 receptors.

Hoch RC, Schraufstätter IU, Cochrane CG.

J Lab Clin Med. 1996 Aug;128(2):134-45. Review. No abstract available.

PMID:
8765209
10.

Efficacy of synthetic peptide-containing surfactant in the treatment of respiratory distress syndrome in preterm infant rhesus monkeys.

Revak SD, Merritt TA, Cochrane CG, Heldt GP, Alberts MS, Anderson DW, Kheiter A.

Pediatr Res. 1996 Apr;39(4 Pt 1):715-24.

PMID:
8848350
11.

The efficacy and safety of KL4-surfactant in preterm infants with respiratory distress syndrome.

Cochrane CG, Revak SD, Merritt TA, Heldt GP, Hallman M, Cunningham MD, Easa D, Pramanik A, Edwards DK, Alberts MS.

Am J Respir Crit Care Med. 1996 Jan;153(1):404-10.

PMID:
8542150
13.

Hydrogen peroxide as a potent bacteriostatic antibiotic: implications for host defense.

Hyslop PA, Hinshaw DB, Scraufstatter IU, Cochrane CG, Kunz S, Vosbeck K.

Free Radic Biol Med. 1995 Jul;19(1):31-7.

PMID:
7635356
14.

The role of Tyr13 and Lys15 of interleukin-8 in the high affinity interaction with the interleukin-8 receptor type A.

Schraufstätter IU, Ma M, Oades ZG, Barritt DS, Cochrane CG.

J Biol Chem. 1995 May 5;270(18):10428-31.

15.

Polylysine domain of K-ras 4B protein is crucial for malignant transformation.

Jackson JH, Li JW, Buss JE, Der CJ, Cochrane CG.

Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12730-4.

16.

Identification of a regulatory domain of the interleukin-6 receptor.

Grube BJ, Cochrane CG.

J Biol Chem. 1994 Aug 12;269(32):20791-7.

17.

Protein-phospholipid interactions in pulmonary surfactant. The Parker B. Francis Lectureship.

Cochrane CG, Revak SD.

Chest. 1994 Mar;105(3 Suppl):57S-62S. Review.

PMID:
8131614
18.

Domains of the human neutrophil N-formyl peptide receptor involved in G protein coupling. Mapping with receptor-derived peptides.

Schreiber RE, Prossnitz ER, Ye RD, Cochrane CG, Bokoch GM.

J Biol Chem. 1994 Jan 7;269(1):326-31.

19.

Restitution of superoxide generation in autosomal cytochrome-negative chronic granulomatous disease (A22(0) CGD)-derived B lymphocyte cell lines by transfection with p22phax cDNA.

Maly FE, Schuerer-Maly CC, Quilliam L, Cochrane CG, Newburger PE, Curnutte JT, Gifford M, Dinauer MC.

J Exp Med. 1993 Dec 1;178(6):2047-53.

20.

Multiple sites on IL-8 responsible for binding to alpha and beta IL-8 receptors.

Schraufstätter IU, Barritt DS, Ma M, Oades ZG, Cochrane CG.

J Immunol. 1993 Dec 1;151(11):6418-28.

PMID:
8245475
21.

Signal transducing properties of the N-formyl peptide receptor expressed in undifferentiated HL60 cells.

Prossnitz ER, Quehenberger O, Cochrane CG, Ye RD.

J Immunol. 1993 Nov 15;151(10):5704-15.

PMID:
8228256
22.

The role of the third intracellular loop of the neutrophil N-formyl peptide receptor in G protein coupling.

Prossnitz ER, Quehenberger O, Cochrane CG, Ye RD.

Biochem J. 1993 Sep 1;294 ( Pt 2):581-7.

23.
24.

Reconstitution of recombinant N-formyl chemotactic peptide receptor with G protein.

Schreiber RE, Prossnitz ER, Ye RD, Cochrane CG, Jesaitis AJ, Bokoch GM.

J Leukoc Biol. 1993 Apr;53(4):470-4.

PMID:
8482927
25.

The rabbit neutrophil N-formyl peptide receptor. cDNA cloning, expression, and structure/function implications.

Ye RD, Quehenberger O, Thomas KM, Navarro J, Cavanagh SL, Prossnitz ER, Cochrane CG.

J Immunol. 1993 Feb 15;150(4):1383-94.

PMID:
8432984
26.

Absence of G(i) proteins in the Sf9 insect cell. Characterization of the uncoupled recombinant N-formyl peptide receptor.

Quehenberger O, Prossnitz ER, Cochrane CG, Ye RD.

J Biol Chem. 1992 Oct 5;267(28):19757-60.

27.

Isolation of a cDNA that encodes a novel granulocyte N-formyl peptide receptor.

Ye RD, Cavanagh SL, Quehenberger O, Prossnitz ER, Cochrane CG.

Biochem Biophys Res Commun. 1992 Apr 30;184(2):582-9.

PMID:
1374236
28.

Elevation of tissue kallikrein and kinin in the airways of asthmatic subjects after endobronchial allergen challenge.

Christiansen SC, Proud D, Sarnoff RB, Juergens U, Cochrane CG, Zuraw BL.

Am Rev Respir Dis. 1992 Apr;145(4 Pt 1):900-5.

PMID:
1554219
29.
30.

Pulmonary surfactant protein B (SP-B): structure-function relationships.

Cochrane CG, Revak SD.

Science. 1991 Oct 25;254(5031):566-8.

PMID:
1948032
31.

Characterization of a human cDNA that encodes a functional receptor for platelet activating factor.

Ye RD, Prossnitz ER, Zou AH, Cochrane CG.

Biochem Biophys Res Commun. 1991 Oct 15;180(1):105-11.

PMID:
1656963
32.

Cellular injury by oxidants.

Cochrane CG.

Am J Med. 1991 Sep 30;91(3C):23S-30S. Review.

PMID:
1928208
33.

Transmembrane signalling by the N-formyl peptide receptor in stably transfected fibroblasts.

Prossnitz ER, Quehenberger O, Cochrane CG, Ye RD.

Biochem Biophys Res Commun. 1991 Aug 30;179(1):471-6.

PMID:
1883372
34.
35.

The use of synthetic peptides in the formation of biophysically and biologically active pulmonary surfactants.

Revak SD, Merritt TA, Hallman M, Heldt G, La Polla RJ, Hoey K, Houghten RA, Cochrane CG.

Pediatr Res. 1991 May;29(5):460-5.

PMID:
1896249
36.

Mechanisms of oxidant injury of cells.

Cochrane CG.

Mol Aspects Med. 1991;12(2):137-47. Review. No abstract available.

PMID:
2072822
37.
38.

Farnesol modification of Kirsten-ras exon 4B protein is essential for transformation.

Jackson JH, Cochrane CG, Bourne JR, Solski PA, Buss JE, Der CJ.

Proc Natl Acad Sci U S A. 1990 Apr;87(8):3042-6.

39.

Mechanisms of hypochlorite injury of target cells.

Schraufstätter IU, Browne K, Harris A, Hyslop PA, Jackson JH, Quehenberger O, Cochrane CG.

J Clin Invest. 1990 Feb;85(2):554-62.

40.

Damage to the bases in DNA induced by stimulated human neutrophils.

Jackson JH, Gajewski E, Schraufstatter IU, Hyslop PA, Fuciarelli AF, Cochrane CG, Dizdaroglu M.

J Clin Invest. 1989 Nov;84(5):1644-9.

41.

Inhibition of human bronchial kallikrein in asthma.

Christiansen SC, Zuraw BL, Proud D, Cochrane CG.

Am Rev Respir Dis. 1989 May;139(5):1125-31.

PMID:
2785358
42.

Elevated plasma levels of ED1+ ("cellular") fibronectin in patients with vascular injury.

Peters JH, Maunder RJ, Woolf AD, Cochrane CG, Ginsberg MH.

J Lab Clin Med. 1989 May;113(5):586-97.

PMID:
2715681
43.

Oxidant-induced DNA damage of target cells.

Schraufstätter I, Hyslop PA, Jackson JH, Cochrane CG.

J Clin Invest. 1988 Sep;82(3):1040-50.

44.

The Hageman factor-dependent system in the vascular permeability reaction.

Yamamoto T, Kozono K, Kambara T, Cochrane CG.

Biochim Biophys Acta. 1988 Aug 11;966(2):196-206.

PMID:
3401504
45.
46.
47.

Leukocyte-induced tissue injury.

Jackson JH, Cochrane CG.

Hematol Oncol Clin North Am. 1988 Jun;2(2):317-34. Review.

PMID:
2839462
48.

Use of human surfactant low molecular weight apoproteins in the reconstitution of surfactant biologic activity.

Revak SD, Merritt TA, Degryse E, Stefani L, Courtney M, Hallman M, Cochrane CG.

J Clin Invest. 1988 Mar;81(3):826-33.

49.

Mechanisms of oxidant-mediated cell injury. The glycolytic and mitochondrial pathways of ADP phosphorylation are major intracellular targets inactivated by hydrogen peroxide.

Hyslop PA, Hinshaw DB, Halsey WA Jr, Schraufstätter IU, Sauerheber RD, Spragg RG, Jackson JH, Cochrane CG.

J Biol Chem. 1988 Feb 5;263(4):1665-75.

50.

The quaternary structure of the plasma membrane b-type cytochrome of human granulocytes.

Parkos CA, Allen RA, Cochrane CG, Jesaitis AJ.

Biochim Biophys Acta. 1988 Jan 20;932(1):71-83.

PMID:
3337799

Supplemental Content

Loading ...
Support Center